Week 298 Review - Very quiet but most holdings drop

A very quiet week with no fallers or risers of 5% or more, but with most shares falling in value it was a repeat of last week. The difference between cost and value worsened by £2,484 and is now £23,983 in deficit, with total portfolio value dropping to £115,562.

Share of the Week is APAX:Apax Global Alpha, which wins for the second week in a row despite only rising 3%. This does reveal the steady progress being made here, even better thanks to the 7% dividend.

Just an extension of last week.

Here's the ISA and shares portfolio after week 38 of year 6.

			Weekly Change
Cash	£9.79		+£0
Portfolio cost	£67,058.62		+£0
Portfolio sell value (bid price-commission)	£54,483.59	(-18.8%)	-£1,169.19
Potential profits	£6,813.67		-£120.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£4,629.22		+£0
Yr 6 projected avg monthly profit	£524.05	(15.0%)	-£14.16
Total Dividends	£1,343.15		+£0
Total Profit from sales	£25,055.83		+£0
Average monthly cash profit	£380.00	(10.9%)	-£1.28
(Sold stocks profit + Dividends - Fees  / Months)
Compound performance	63%		+0%

Potential profits down thanks to a small drop in JLP:Jubilee Metals, and the 1p drop in OPTI:Optibiotix did for a big chunk of the rest. Long term performance still above 10% target.

The SIPP looks like this after week 282 overall and week 22 of year 6.

			Weekly Change
Cash	£269.37		-£76.71
Portfolio cost	£69,574.61		+£418.54
Portfolio sell value (bid price - commission)	£58,935.02	(-15.3%)	-£1,280.42
Potential profits	£3,968.61		-£338.73
Yr 6 Dividends	£573.61		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£5,295.11		+£209.73
Yr 6 projected avg monthly profit	£1,139.48	(32.0%)	-£10.98
Total Dividends	£2,640.69		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£20,754.55		+£209.73
Average monthly cash profit	£348.68	(9.8%)	+£2.00
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	53%		+0%

I sold some shares this week in order to top up on OPTI:Optibiotix, as I decided if the CEO is willing to buy more on the open market when he already owns millions, then it would be rude not to join him.

I sold 500 CAML:Central Asia Metals and made £415.15 (44.8%) profit, and used the proceeds to buy 2,946 OPTI:Optibiotix at 52.3p costing £1,549.71. Unfortunately I then decided to see how many shares I had, and when I discovered it was just under 150,000 I decided I needed to crack that milestone.

I sold 91 shares of CMCL:Caledonia Mining at a loss of £205.42 (17.4%) as I admitted to myself it was a terrible mistake re-investing in this serial under-performer and I was willing to take a small hit as I expect OPTI to climb way more than 17% when they finally start moving. I bought another 1,841 at 51.65p costing £959.83. That reduces my weighted average SIPP cost to 62p a share. Now I'm over 150k shares, each 1p change is worth £1,500.

The trading account looks like this after week 248 overall and week 40 of year 5.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,605.28	(-32.4%)	-£35.19
Potential profits	£0.00		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£651.51		+£0
Yr 5 projected avg monthly profit	£71.90	(36.3%)	-£1.84
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£17.44	(8.8%)	-£0.07
(Sold stocks profit + Dividends - Fees  / Months)

Everything fell except IQE:IQE so not a great week. Still no sign of DDDD:4D Pharma doing what I thought it would. Clearly Nasdaq listing has done nothing to encourage high value American investors.

Another late one and another depressing one, so no compulsion to write more. I need a good week to lift my flagging spirits.